Sun Pharmaceuticals Industries Ltd

Sun Pharma.Inds. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sun Pharmaceuticals Industries Ltd

₹ 1,771 -0.35%
22 Nov 11:17 a.m.
sunpharma.com BSE: 524715 NSE: SUNPHARMA
About

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.[1] It is the largest pharmaceutical company in India.[2]

Key Points

Product Offerings
The company produces a comprehensive and diverse portfolio of generic and specialty medicines targeting wide spectrum of chronic and acute treatments. Its product portfolio includes generics, branded generics, specialty, difficult-to-make technology intensive products, anti-retrovirals, APIs and intermediates.[1] It offers medicines in all form of dosages i.e. injectables, sprays, ointments, creams, liquids, tablets and capsules.[2]

Website BSE NSE
  • Market Cap ₹ 4,25,006 Cr.
  • Current Price ₹ 1,771
  • High / Low ₹ 1,960 / 1,184
  • Stock P/E 154
  • Book Value ₹ 98.3
  • Dividend Yield 0.76 %
  • ROCE 13.4 %
  • ROE 12.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 18.0 times its book value
  • Company has a low return on equity of 6.88% over last 3 years.
  • Company has high debtors of 159 days.
  • Working capital days have increased from 96.0 days to 183 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE Sensex Nifty 50 BSE 500 BSE Healthcare BSE 100

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
4,143 3,771 4,007 4,933 5,285 4,646 5,948 4,466 5,096 5,074 5,639 4,498 5,128
3,279 3,114 3,007 3,483 3,622 3,646 3,588 3,517 3,710 3,715 3,746 3,737 3,789
Operating Profit 864 656 1,000 1,450 1,663 999 2,361 949 1,386 1,359 1,894 761 1,339
OPM % 21% 17% 25% 29% 31% 22% 40% 21% 27% 27% 34% 17% 26%
284 305 -1,355 49 42 68 -2,817 14 107 7 119 83 86
Interest 104 85 91 87 93 131 161 158 194 215 218 216 244
Depreciation 334 355 354 374 384 430 412 415 393 400 393 370 286
Profit before tax 711 521 -800 1,037 1,228 506 -1,030 390 907 751 1,402 258 896
Tax % -14% 1% 61% 2% 1% 4% -1% 2% 2% 4% 38% 8% 4%
809 515 -1,286 1,012 1,213 487 -1,021 381 889 721 868 238 863
EPS in Rs 3.37 2.15 -5.36 4.22 5.06 2.03 -4.25 1.59 3.70 3.01 3.62 0.99 3.60
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
2,432 2,829 8,028 7,719 7,684 8,982 10,303 12,532 14,116 15,586 20,812 20,275 20,339
1,919 2,810 8,581 8,130 7,559 7,998 8,513 9,815 11,849 12,917 14,389 14,761 14,986
Operating Profit 513 19 -552 -410 125 985 1,790 2,717 2,267 2,669 6,423 5,514 5,352
OPM % 21% 1% -7% -5% 2% 11% 17% 22% 16% 17% 31% 27% 26%
236 -2,700 205 367 504 171 23 1,506 93 -624 -2,609 320 295
Interest 0 18 551 574 224 388 541 408 268 388 472 784 892
Depreciation 86 102 661 464 422 487 553 562 1,236 1,350 1,601 1,601 1,448
Profit before tax 663 -2,801 -1,559 -1,082 -17 280 719 3,253 856 307 1,741 3,450 3,307
Tax % 22% 1% -5% 0% 36% -9% -14% 1% 2% 133% 3% 17%
517 -2,829 -1,474 -1,088 -23 306 817 3,211 842 -100 1,691 2,858 2,690
EPS in Rs 2.49 -13.66 -7.12 -4.52 -0.10 1.27 3.40 13.38 3.51 -0.42 7.05 11.91 11.22
Dividend Payout % 50% -11% -42% -22% -3,677% 157% 81% 30% 214% -2,400% 163% 113%
Compounded Sales Growth
10 Years: 22%
5 Years: 15%
3 Years: 13%
TTM: 1%
Compounded Profit Growth
10 Years: 49%
5 Years: 10%
3 Years: 50%
TTM: -28%
Stock Price CAGR
10 Years: 8%
5 Years: 32%
3 Years: 31%
1 Year: 48%
Return on Equity
10 Years: 4%
5 Years: 7%
3 Years: 7%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 104 207 207 241 240 240 240 240 240 240 240 240 240
Reserves 7,685 7,201 22,579 21,650 20,773 22,083 22,604 24,156 26,699 24,348 23,508 23,454 23,353
43 2,409 6,811 5,829 6,047 6,884 6,437 6,406 7,358 5,074 7,791 11,227 11,784
1,414 4,548 7,849 6,547 6,810 7,585 8,434 7,608 9,438 11,103 9,448 6,143 6,629
Total Liabilities 9,246 14,364 37,446 34,266 33,869 36,792 37,714 38,410 43,735 40,765 40,987 41,065 42,005
1,136 1,267 3,185 3,575 4,039 4,645 4,978 5,229 9,669 9,713 8,712 7,737 7,631
CWIP 348 480 1,091 768 1,100 988 643 597 1,090 829 853 766 517
Investments 4,318 7,016 25,876 22,372 19,333 18,355 17,904 17,362 15,537 15,549 12,613 12,430 12,432
3,445 5,601 7,294 7,552 9,397 12,804 14,189 15,223 17,438 14,675 18,810 20,132 21,425
Total Assets 9,246 14,364 37,446 34,266 33,869 36,792 37,714 38,410 43,735 40,765 40,987 41,065 42,005

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
106 -2,405 149 -1,254 -1,621 -1,171 1,242 1,306 -417 7,636 507 -292
456 517 2,642 3,640 2,381 1,394 431 1,483 1,452 -2,697 -686 -265
-509 1,742 -2,674 -2,368 -753 -272 -1,469 -2,871 -1,000 -4,871 169 474
Net Cash Flow 53 -145 117 17 7 -50 205 -82 36 68 -9 -84

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 111 126 82 94 129 214 178 180 170 99 125 159
Inventory Days 354 315 227 260 256 218 277 210 245 220 240 223
Days Payable 148 130 164 216 229 262 214 170 288 175 188 171
Cash Conversion Cycle 317 311 146 138 155 170 242 220 127 144 177 211
Working Capital Days 210 370 -85 9 -35 83 62 122 110 -26 131 183
ROCE % 8% 0% -6% -3% -0% 5% 8% 11% 4% 8% 17% 13%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48% 54.48%
13.00% 14.44% 14.95% 16.00% 16.87% 16.88% 16.48% 16.78% 17.08% 17.72% 17.23% 18.01%
20.99% 20.02% 19.66% 19.64% 19.08% 19.18% 19.65% 19.56% 19.42% 18.71% 19.17% 18.48%
0.00% 0.00% 0.00% 0.06% 0.06% 0.06% 0.09% 0.10% 0.11% 0.11% 0.11% 0.11%
11.53% 11.06% 10.91% 9.80% 9.52% 9.38% 9.28% 9.05% 8.92% 8.97% 9.00% 8.89%
No. of Shareholders 6,80,8006,62,3846,47,1676,43,5126,32,3376,25,2526,24,5616,16,5886,12,6266,31,3926,73,2176,57,317

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls